RBA Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-25,472
| Closed | -$4.68M | – | 24 |
|
|
2021
Q2 | $4.68M | Sell |
25,472
-221
| -0.9% | -$40.6K | 9.94% | 3 |
|
|
2021
Q1 | $3.93M | Sell |
25,693
-265
| -1% | -$40.5K | 3.33% | 8 |
|
|
2020
Q4 | $4.06M | Buy |
25,958
+47
| +0.2% | +$7.34K | 2.44% | 7 |
|
|
2020
Q3 | $2.97M | Buy |
25,911
+490
| +2% | +$56.1K | 2% | 14 |
|
|
2020
Q2 | $2.85M | Buy |
25,421
+865
| +4% | +$97.1K | 2.08% | 15 |
|
|
2020
Q1 | $2.21M | Buy |
24,556
+888
| +4% | +$79.7K | 1.91% | 16 |
|
|
2019
Q4 | $2.56M | Buy |
+23,668
| New | +$2.56M | 1.74% | 26 |
|